Abstract A significant proportion of prevalent kidney transplant recipients (KTRs) will have decreased kidney function and be at risk for chronic kidney disease (CKD)-related complications, including cardiovascular disease, mineral and…
Abstract Since the first kidney transplant procedure in 1954, evolution in immunosuppression management, surgical practice, and organ preservation has improved transplant outcomes and reduced perioperative morbidity. As a result, kidney…
Abstract: This chapter addresses peritoneal dialysis solutions, peritoneal dialysis adequacy, and prescriptions and residual kidney function. Keywords biocompatible, glucose degradation products, glucose polymer solutions, PD adequacy, PD solutions, peritoneal membrane…
Abstract The diagnosis of acute kidney injury (AKI) has relied on serum creatinine and urine output, two biomarkers that are insensitive and nonspecific, particularly early in the course of the…
Abstract Acute kidney injury (AKI) is characterized by sudden (i.e., hours to days) impairment of kidney function. AKI is an increasingly common complication in hospitalized individuals around the world and…
Abstract This chapter will review the recurrence and de novo presentation of renal diseases in the kidney transplant recipient. Primary glomerular, secondary glomerular, and nonglomerular disorders and their frequency and…
Abstract Kidney transplantation is now the standard of care for properly selected patients with end-stage renal disease. Successful transplantation provides remarkable improvement in quality of life and decreases recipient mortality…
Abstract The indications, timing of initiation, and choice of modality and intensity of delivered therapy are factors that must be considered in prescribing renal replacement therapy (RRT) to patients with…
Abstract Translating advances in our understanding of the pathogenesis of acute kidney injury (AKI) to clinical trials require robust animal models for AKI, identification of targets for AKI relevant to…
Abstract Kidney transplantation is the treatment of choice for selected patients with end-stage renal disease (ESRD) because of improvements in patient survival, quality of life, and reduced long-term health costs….
